The carcinogenic effect in hepatoma cell line and human HCC tissues, along with in vivo tumor promotion in the transgenic mice, provides a novel role of RBMY as a male-specific oncogene to explain the male predominance of liver cancer. This evidence concerns the gene RBMY1A1 and liver cancer.